[1] Navilyst Medical was founded in February 2008 out of the $425 million Avista Capital Partners acquisition of Boston Scientific's Fluid Management and Vascular Access division.

The acquisition was seen as a way to focus on "opportunities it sees with vein-access devices, instead of competing for resources with many other projects inside the larger company [of Boston Scientific]," primarily within the hospital realm.

[1][2] The purchase included Boston Scientific's manufacturing plant for NAMIC angiography and angioplasty fluid management devices in Glens Falls, NY.

[3][4] In January 2012, news broke that vascular device manufacturer AngioDynamics, Inc. would be purchasing Navilyst for $372 million, calling the opportunity "an excellent platform for future revenue and earnings growth, as well as substantial cash flow generation.

[7] A year later, the Glens Falls plant was hit with a warning letter from the FDA concerning faults with design control and real-time aging testing found during on-site inspections, though the company strove "to rectify the deficiencies promptly.